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Introduction post-translational modifications [12] of a-crystallins 
we refer to other recent reviews.
a-Crystallins owe their name to the fact that they are 
major eye lens proteins in vertebrates. They are abun­
dantly present in the lens and have a prominent role in 
maintaining the transparency and retractile properties 
of the lens (reviewed in [1-3]). There are two types of 
related subunits, aA  and aB, each of about 20 kDa, of 
which aB  is also expressed at significant levels in many 
different tissues outside the lens [4], a-Crystallins exist 
as large homo- or hetcromeric complexes, contain­
ing about 30-40 subunits. Their tertiary and quater­
nary structures are unknown. Initially it was observed 
that» on ihe basis of sequence homology, a-crystallins 
belong to the family of small heat shock proteins (hsps) 
[5], This family is characterized by the presence of an 
approximately 100 amino acid long conserved domain, 
often called the a-crystallin domain. a-Crystallins and 
small hsps arc not only evolutionarily related but they 
also behave very similarly in many respects. They actu­
ally can form mixed complexes in tissues were both 
proteins are expressed [6 , 7], a-Crystallins, like oth­
er small hsps, have chaperone-like properties in that 
they can prevent stress-induced aggregation of pro­
teins [8], Furthermore, mammalian aB-crystallin is 
stress-inducible, and the presence of a-crystallins in 
cultured cells leads to an enhanced survival of these 
cells after a period of stress [9]. aB-Crystallin is also 
implicated in the pathogenesis of various degenerative 
diseases.
In this mini review we will mainly discuss the struc­
tural and functional aspects of a-crystallins. For gene 
regulation [10], evolutionary relationships [11] and
Structure of a-crystallins
Electron microscopic pictures of normal 700-800 kDa 
a-crystallin complexes display heterogeneous globu­
lar particles of approximately 14-18 nm [13-15]. They 
have sometimes been observed to have a torus-like 
structure [16, 17]. a-Crystallin is predominantly a /3- 
sheet protein with less than 10% a-helical structure 
[18,19]. The subunits presumably have a two-domain 
structure [20- 22] with an about 10 amino acids long 
flexible C-terminal extension [23,24]. Various models 
have been proposed for the quaternary structure of the 
a-crystallin complex. A favored model is the three- 
layered spherical structure based on studies that imply 
three different environments for a-crystallin [25, 26] 
(see Fig. 1 A and B). A micellar complex has also 
been proposed [27, 28]. In this structure, the rather 
hydrophobic N-terminal domains of the subunits are 
oriented towards the center of the aggregate and the 
more hydrophilic C-terminal domains are exposed to 
the surface. Another model is based upon a minimal 
subunit of tetrameric arrangement [29] which is formed 
when the N-terminal domain of a-crystallin is removed 
[21] or in the presence of 1% deoxycholate [30] (see 
Fig. 1C). More recently, a GroEL-like structure has 
been proposed, consisting of two annular layers of 
approximately 20 subunits, able to bind unfolded pro­
teins in the hole in the middle of the complex [31, 32] 
(see Fig. ID). These models may help to explain the 
function of a-crystallin. Complete understanding of
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Fig. 1. Schematic representations of various models for the quaternary structure of a-crystallin. (A) Three-layer model of Bindels et a l  [25] 
composed of a core of 13 subunits, a second layer of 14 subunits and an outer layer of 16 chains. The white and dark spheres indicate the a  A and 
aB subunits, respectively. (B) Three-layer model of Tardieu et a t [26]. First layer is made up of 12 subunits (grey spheres) second layer of 24 
subunits (white spheres) and third layer of 12 subunits (dark spheres). (C) Rhombododecahedric structure model by Wistow [29] is composed 
of 48 subunits and has 12 faces. Each face consists of the C-terminal domains (indicated by peanut-shapes) in atetrameric arrangement formed 
through identical a-b interactions. The tetramers associate by identiacal c-d interactions. (D) GroEL-like structure of Carver et al. [31]. Two 
annuli each of 20 subunits, laid on top of each other. The smaller spheres indicate the N-terminal domain of each subunit and the larger spheres 
the C-terminal domains. The squiggly lines indicate the flexible C-terminal tails.
the spatial configuration, however, clearly awaits X- 
ray crystallographic analysis.
The chaperone-like function of a-crystallins
Lens tissue contains a very high concentration of pro­
teins -  over 50% of wet weight in some species -  of 
which the soluble structural proteins, the various unre­
lated crystallins, constitute over 90% [3]. Transparen­
cy of the lens is essential for its function, and depends 
on a balanced interplay of attractions and repulsions 
of the crystallins to obtain a proper short-range order 
[33, 34]. Disturbance of this order by protein modifi­
cations or physical stress may induce the formation of 
large protein aggregates. Such aggregates would cause 
light-scattering, leading to opacification of the lens.
In vitro experiments have shown that a-crystallins 
may be essential for preventing protein aggregation 
in the lens [8]. The total soluble protein fraction of a 
lens homogenate is very heat stable. It can be heat­
ed to 60 °C without protein aggregation and scatter­
ing to occur. If, however, a-crystallin is selective­
ly removed by ultracentrifugation, the remaining lens 
proteins aggregate when heated at 60 °C. a-Crystallin 
binds to the soluble denaturing proteins and in this 
way probably prevents random protein aggregation. 
The denatured proteins bind relatively stable to the 
a-crystallin complex [35]. Although a-crystallin can 
bind ATP [36], the denatured substrate is not released 
upon incubation with ATP [37]. Stoichiometric anal­
ysis of the a-crystallin complex with denatured 7 -
crystallin demonstrated that a-crystallin can bind the 
soluble denatured substrate up to a 1:1 monomer ratio 
[38]. Together with the finding that the proteins bound 
to the a-crystallin complex are not clustered [39], it is 
likely that every monomer in the a-crystallin aggregate 
can bind a denatured substrate.
a-Crystallin not only suppresses heat-induced 
aggregation of lens proteins, but also of non-lenticular 
proteins such as alcohol dehydrogenase, citrate syn­
thase, a-glucosidase and carbonic anhydrase [8 , 35, 
37]. The efficiency of aggregate prevention is not the 
same for different proteins and may depend on how 
well a-crystallin can interact with the unfolded pro­
tein [38, 40]. Prevention of aggregation of an enzyme 
by a-crystallin seems not to preserve the functional 
activity, as has been shown for alcohol dehydrogenase 
[8, 41]. This is very likely caused by partial unfold­
ing of the protein but may also be a result of blocking 
the active site of the enzyme by the interaction with 
a-crystallin.
Interestingly, refolding of urea- or guanidine- 
denatured proteins is under certain conditions facili­
tated by the presence of a-crystallin. Removal of the 
denaturant often results in a non-functional aggrega­
tion of the protein. In the presence of a-crystallin, 
however, such aggregation can be prevented [8], and 
for a-glucosidase and citrate synthase a more efficient 
refolding could be observed [37], Under normal phys­
iological conditions, several types of insults, such as 
UV light and protein oxidation and glycation, can dam­
age proteins in the lens. This may eventually lead to 
the formation of cataract. Under these conditions a-
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crystallin also may act as a chaperone. Wang and Spec- Function of a-crystallins outside the lens 
tor have shown that 7 -crystallin aggregates after oxida­
tion, which can be partially prevented by the presence Several eye lens crystallins, especially in non- 
of a-crystallin [42]. Glycation-induced inactivation of mammalian vertebrates, have been identified as house- 
glucose-6 -phosphate, an enzyme which looses activity keeping enzymes (for recent review see [3,54]). In the 
in cataractous lenses, can be prevented by a-crystallin
prevent UY-
course of evolution such genes have been upregulat- 
ed in the lens, and now serve an additional function
gation oi 7 -crystallin, but only at elevated tempera- as structural lens proteins. According to this model, 
tures [44]. Below 30 °C a-crystallin does not protect also the primordial a-crystallin gene already coded
the UV-damaged 7 -crystallin, suggesting that at lower 
temperatures no binding sites for non-native proteins 
are available.
In the lens, up to 30% of aA  and aB occur in a 
phosphorylated form. In aA-crystallin a single serine 
at position 122 , and in aB two or three serines at posi­
tions 1ft, 45 and 59 can be phosphorylated [45^47]. 
This phosphorylation is probably catalyzed by cAMP- 
dependent protein kinase [48] and is essentially irre­
versible in the lens-iiber cells, but may be reversible 
in other cell types [49], Interestingly, a-crystallin is 
capable of serine specific autophosphorylation in vitro 
[50], which in the case of aA  is strongly enhanced 
by the conversion of the high molecular weight aggre­
gate to the tetrameric form [30]. Phosphorylation of a- 
crystallin does not seem to affect the ability of the sub­
units to associate [51 ], but may cnhance the chaperone­
like function, especially of aA, in vitro (M. A. M. van 
Boekel, unpubl.).
Other modifications may also affect the chaperone- 
like function. In rodents up to 15% of aA-crystallin 
is present in a modified form, aA mfl, which contains 
an insert of 23 amino acid residues as a result of alter­
native splicing. Purified mAtn* forms larger oligomers 
and displays a diminished chaperone activity compared 
with aA  [52], In cataractous lenses truncated forms of 
a-crystallin can be detected with reduced chaperone 
activity 153]. Removal of about 10 amino acid residues 
at the C-terminus of a-crystallin caused already the 
loss of the chaperone activity [24].
Lens a-crystallins have a very long half-life and 
undergo a whole series of modifications, such as 
deamidation, raccmization, acétylation, glycation 
and age-dependent truncation [12]» Several of these 
types of post-translational modifications decrease the 
chaperone-like activity of a-crystallin (M< A. M. van 
Bockel, unpubl,, and [19]).
for a small hsp in non-lens tissue before having been 
recruited as a crystallin gene. Around that time it must 
have undergone a gene duplication, giving rise to the 
aA  and aB-crystallin genes [11]. a-Crystallin is pre­
dominantly a lens protein. Outside the lens it is present 
in the retina [17] and in very low amounts in spleen 
and thymus [4,55]. So far, no heat inducibility of aA- 
crystallin has been described. In addition to being a 
lens protein, aB-crystallin is also expressed in many 
different tissues. Relatively high levels are found in 
heart, striated muscle, kidney and brain tissue [4, 56,
57].
aB-Crystallin is stress-inducible in different cell 
types. In NIH 3T3 fibroblasts expressing certain onco­
genes, enhanced aB-crystallin expression is induced 
under several stress conditions such as heat shock, 
cadmium or arsenite exposure [58]. Also in various 
glioma cell lines different types of physical and chem­
ical stress enhance aB-crystallin expression [59, 60]. 
Like the small hsp genes, the aB-crystallin gene con­
tains a heat-shock element in its 5' flanking region 
(reviewed in [10]).
aB-Crystallin is often expressed and induced 
together with the small hsp. However, their expres­
sion is differentially regulated. In rat astrocytes, some 
stimuli cause an increase in both aB and hsp27 mRN A, 
whereas other types of stress, such as hypertonic stress 
or TNFa exposure, result in aB-mRNA accumulation 
without a change in the level of hsp27-mRNA [61].
One important function of the enhanced expression 
of aB-crystallin is the protection of the cell during peri­
ods of stress. Evidence for this is the strong correlation 
between increased expression of aB-crystallin and the 
enhanced resistance of the cell to stress [9, 62, 87]. 
Also aA-crystallin, which is not stress inducible, con­
fers cellular thermoresistance [63]. How a-crystallin 
is able to increase the thermotolerance of the cell is not 
understood at all.
Several reports suggest that aB-crystallin interacts 
with, and thus may protect the cytoskeletal structures 
in the cell. Studies on Alexander’s disease, a neu- 
rodegenerative disorder in humans, first revealed the
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association of aB-crystallin with glial fibrillary acidic 
protein (GFAP) which is a major type III intermedi­
ate filament protein of astrocytes [64], Other exam­
ples of redistribution of intermediate filament networks 
exist in human pathologies, in which aB-crystallin 
appears as associated inclusions of the neurofilament- 
containing Lewy body and the cytokeratin-containing 
Mallory body [65-67]. The cause of the accumulation 
of aB-crystallin in diseased organs is unclear, but may 
represent the reaction to some types of stress. In heart 
and slow muscle, aB-crystallin is localized in the Z 
bands where the desmin filaments occur [68], Interme­
diate filament arrays can be dramatically rearranged by 
either heat shock or exposure to heavy metals or chemi­
cal poisons [69,70]. In cell lines in which aB-crystallin 
is abundantly present, there is a transient relocaliza­
tion of aB-crystallin from the detergent-soluble cyto­
plasmic fraction to the non-ionic detergent-insoluble 
nuclear/cy to skeletal fraction [58, 71, 72]. The disap­
pearance from the cytoplasmic fraction is fast, within 
15 min after heat shock, and remains for about 2 h 
[73]. Both the cytoskeletal rearrangement and the relo­
calization of aB-crystallin are fully reversible events, 
which allows the speculation that aB-crystallin plays 
an active role in the redistribution of intermediate fila­
ments after stress.
The relocalisation of aB-crystallin is dependent 
on the type of stress. Under arsenite exposure human 
glioma cells aB-crystallin expression is induced, but 
aB  remains in the soluble fraction [59]. Further­
more, treatment of human ovarian carcinoma cells 
with colchicin causes a collapse of the intermediate 
filaments which is independent of the relocalisation of 
aB-crystallin [71]. This may mean that the protective 
role of aB-crystallin is dependent upon the type of 
stress-condition,
a-Crystallin may not only be implicated in the 
remodelling of intermediate filaments under stress but 
also under non-stress conditions. An indication for this 
is that during the development of certain tissues aB- 
crystallin is present in the cells which undergo exten­
sive morphological changes [74, 75]. Furthermore, 
reduction of the amount of aB-crystallin in glioma 
cells by antisense-transfection changed the morpholo­
gy of the cells [62]. Especially a loss of stress fibers 
could be observed.
The possible protective role of aB-crystallin with 
regard to the cytoskeletal network in cells exposed to 
stress has been underlined by in vitro data. In vitro 
experiments have shown that aB-crystallin is able to 
bind to actin, desmin (a muscle-specific type III inter­
mediate filament protein), GFAP filaments [68 , 76], 
CP49/CP115 filaments [77] and tubulin [78].
Spontaneous aggregation of desmin filaments 
in vitro can be prevented by aB-crystallin [68]. Fur­
thermore, aB-crystallin is able to prevent low pH (6.0) 
induced aggregation of actin filaments at physiologi­
cal ionic strength, a process which might be induced 
by acidification of the cytosol during ischemic stress. 
There is, however, no indication that aB-crystallin can 
act as an inhibitor of actin filament assembly in vitro 
[78]. Such a property has been reported for the small 
hsp [79] and implicated in the actin filament dynamics 
after a stress period [80, 81].
a-Crystallin is able to inhibit the in vitro assembly 
of GFAP and vimentin. The inhibition is independent 
of ATP and of the phosphorylation status of the a -  
crystallin [76]. When added to preformed filaments, a -  
crystallins can increase the soluble pool of GFAP [76]. 
Thus a-crystallin may be implicated in the protection 
and remodelling of intermediate filaments which are 
important processes during development and cell dif­
ferentiation and stress situations. There are some addi­
tional properties of a-crystallin that may turn out to 
be physiological relevant. a-Crystallin and also small 
hsps have protease-inhibitory activity in vitro . One 
mole of a-crystallin is able to bind 13-19 mole of 
elastase [82, 83]. Such a function could be useful to 
prevent degradation of transiently denatured proteins 
during stress. It is, however, not clear if such a function 
exists in vivo.
a-Crystallin, especially aA , is known to interact 
specifically with lens membranes. It appears that bind­
ing to lens membranes requires the presence of the 
major intrinsic protein called MIP or MP26 [84, 85]. 
In lens extract, a-crystallin was detected to be present 
in a DNA-binding protein complex able to bind specif­
ically to the sense DNA strand of a 21-bp conserved 
region located in the murine 7 E-crystallin promoter 
[86]. This may point to an intriguing function of a -  
crystallin.
In summary, a-crystallins are chaperone-like proteins 
which are abundantly present in the lens but also in 
many other tissues. They have, most likely, an impor­
tant role in preventing protein aggregation in the cell 
and may also be involved in maintaining the integrity 
of the cytoskeleton and in eliminating or sequestering 
non-native proteins. Establishing how these functions 
are performed is a major challenge for the years to 
come.
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